Stock-Based Compensation - Summary of RSU activity (Details) - Unvested restricted stock units |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Outstanding and unvested, beginning balance, Number of Units (in shares) | shares | 156,563 |
| Vested, Number of Units (in shares) | shares | (10,113) |
| Outstanding and unvested, ending balance, Number of Units (in shares) | shares | 146,450 |
| Outstanding and unvested, beginning balance, Weighted average grant date fair value (in dollars per share) | $ / shares | $ 4.97 |
| Vested, Weighted average grant date fair value (in dollars per share) | $ / shares | 16.83 |
| Outstanding and unvested, ending balance, Weighted average grant date fair value (in dollars per share) | $ / shares | $ 4.15 |
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|